China's TCM Makers Draw Western-Drug Makers Seeking Market Share
This article was originally published in PharmAsia News
Executive Summary
China's traditional Chinese medicine, already a popular treatment at home, is attracting foreign drug makers such as AtraZeneca, GlaxoSmithKline and Novartis seeking a share of the global TCM market.